Reply to: Utility of Serum S100B as a Marker in SLE Patients During and After the SARS-Cov-2 Pandemic.

Arch Med Res

Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, 81 Meishan Road, Hefei, Anhui 230032, China; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Hefei, Anhui, China. Electronic address:

Published: July 2022

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130680PMC
http://dx.doi.org/10.1016/j.arcmed.2022.05.005DOI Listing

Publication Analysis

Top Keywords

reply utility
4
utility serum
4
serum s100b
4
s100b marker
4
marker sle
4
sle patients
4
patients sars-cov-2
4
sars-cov-2 pandemic
4
reply
1
serum
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!